TESARO Inc. | Mutual Funds
Mutual Funds that own TESARO Inc.
Vanguard Health Care Fund
3,099,228
5.64%
102,597
0.2%
06/30/2018
SPDR S&P Biotech ETF
1,680,331
3.06%
4,323
0.93%
09/06/2018
BB Biotech AG
1,629,743
2.97%
633,550
1.27%
03/31/2018
Vanguard Small Cap Index Fund
966,426
1.76%
13,587
0.03%
07/31/2018
Vanguard Total Stock Market Index Fund
955,118
1.74%
1,012
0%
07/31/2018
CREF Stock Account
773,755
1.41%
672,363
0.02%
03/31/2018
Fidelity OTC Portfolio
701,600
1.28%
-481,900
0.1%
07/31/2018
Fidelity Select Health Care Portfolio
660,000
1.2%
-30,000
0.28%
07/31/2018
Fidelity Select Biotechnology Portfolio
648,307
1.18%
0
0.23%
07/31/2018
iShares Nasdaq Biotechnology ETF
635,346
1.15%
-8,316
0.21%
09/06/2018
| Address |
1000 Winter Street
Waltham Massachusetts 02451
United States
|
|
Employees
|
- |
| Website |
http://www.tesarobio.com |
| Updated |
09/14/2018 |
| TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. It focuses on oncology-based therapeutics and its products include: Rolapitant and Niraparib. The company was founded by Leon Moulder, Jr. |
